Travere Therapeutics (TVTX)
(Delayed Data from NSDQ)
$5.26 USD
-0.13 (-2.41%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.25 -0.01 (-0.19%) 7:58 PM ET
5-Strong Sell of 5 5
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.95 |
EPS Last Quarter | -1.16 |
Last EPS Surprise | 8.66% |
ABR | 1.50 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.10 |
Next Year | -1.86 |
EPS (TTM) | -4.73 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 45.02M | 50.35M | 209.25M | 310.94M |
# of Estimates | 8 | 8 | 8 | 8 |
High Estimate | 60.85M | 62.30M | 224.74M | 513.31M |
Low Estimate | 38.00M | 42.00M | 174.00M | 218.42M |
Year ago Sales | 56.99M | 59.70M | 198.84M | 209.25M |
Year over Year Growth Est. | -21.00% | -15.66% | 5.23% | 48.59% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.95 | -0.81 | -3.10 | -1.86 |
# of Estimates | 9 | 8 | 9 | 9 |
Most Recent Consensus | -0.98 | -0.97 | -3.54 | -1.80 |
High Estimate | -0.55 | -0.63 | -2.43 | 0.16 |
Low Estimate | -1.20 | -1.08 | -4.10 | -2.64 |
Year ago EPS | -1.27 | -1.13 | -5.07 | -3.10 |
Year over Year Growth Est. | 25.20% | 28.32% | 38.86% | 39.93% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 1 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.95 | -0.81 | -3.10 | -1.86 |
7 Days Ago | -0.95 | -0.81 | -3.10 | -1.85 |
30 Days Ago | -0.95 | -0.81 | -3.10 | -1.85 |
60 Days Ago | -0.94 | -0.80 | -3.08 | -1.74 |
90 Days Ago | -0.92 | -0.80 | -3.21 | -1.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.95 | -0.81 | -3.10 | -1.80 |
Zacks Consensus Estimate | -0.95 | -0.81 | -3.10 | -1.86 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 3.34% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.16 | -1.17 | -1.13 | -1.27 | NA |
Estimate | -1.27 | -1.09 | -1.16 | -1.18 | NA |
Difference | 0.11 | -0.08 | 0.03 | -0.09 | -0.01 |
Surprise | 8.66% | -7.34% | 2.59% | -7.63% | -0.93% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more